Publication: Role of telemedicine in the management of oral anticoagulation in atrial fibrillation: a practical clinical approach.
No Thumbnail Available
Identifiers
Date
2022-07-13
Authors
Barrios, Vivencio
Cinza-Sanjurjo, Sergio
García-Alegría, Javier
Freixa-Pamias, Román
Llordachs-Marques, Frederic
Molina, Carlos A
Santamaría, Amparo
Vivas, David
Suárez Fernandez, Carmen
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Compared with face-to-face consultations, telemedicine has many advantages, including more efficient use of healthcare resources, partial relief of the burden of care, reduced exposure to COVID-19, treatment adjustment, organization of more efficient healthcare circuits and patient empowerment. Ensuring optimal anticoagulation in atrial fibrillation patients is mandatory if we want to reduce the thromboembolic risk. Of note, telemedicine is an excellent option for the long-term management of atrial fibrillation patients. Moreover, direct oral anticoagulants may provide an added value in telemedicine (versus vitamin K antagonists), as it is not necessary to monitor anticoagulant effect or make continuous dosage adjustments. In this multidisciplinary consensus document, the role of telemedicine in anticoagulation of this population is discussed and practical recommendations are provided.
Description
MeSH Terms
Administration, Oral
Anticoagulants
Atrial Fibrillation
COVID-19
Humans
Stroke
Telemedicine
Anticoagulants
Atrial Fibrillation
COVID-19
Humans
Stroke
Telemedicine
DeCS Terms
CIE Terms
Keywords
COVID-19, anticoagulation, atrial fibrillation, direct oral anticoagulant, telemedicine, vitamin K antagonist